Nova Eye Medical Ltd (($ELXMF)) announced an update on their ongoing clinical study. Study Overview: Nova Eye Medical Ltd is conducting a clinical ...

Oluwatosin U. Smith, MD, reflects on early experiences caring for pediatric patients with complex glaucoma and how evolving ...

The findings could enable earlier detection and treatment for people affected by the serious eye condition. A research team ...

Two sustained-release procedural pharmaceuticals or drug-delivery options are available in the US: the bimatoprost ...

Nova Eye Medical Ltd (($ELXMF)) announced an update on their ongoing clinical study. Study Overview: The study titled ‘Multicenter Glaucoma Study ...

Iantrek launched AlloFlo Uveo, a bio-interventional surgical treatment that targets the uveoscleral pathway in patients with glaucoma, according to a press release. “Over the past 15 years, glaucoma ...

AND JESS, YOU SAY THIS COULD BE A GAME CHANGER. YOU KNOW, IT REALLY CAN. ABOUT 3 MILLION AMERICANS HAVE GLAUCOMA AND THIS NEW TREATMENT IS BASICALLY AN IMPLANTABLE DRUG FOR THE EYE. AND DOCTORS SAY IT ...

A licensing agreement between SERI and Eyexora Global has launched Y.ora Vision, a new ophthalmic medical device company.

Please provide your email address to receive an email when new articles are posted on . Switching patients to an interventional glaucoma treatment paradigm offers benefits, but ophthalmologists must ...

US initiative follows recent CE certification of Ciliatech’s flagship eye implant, Intercil® Uveal Spacer, novel treatment for patients with mild to moderate glaucomaDecisive move unlocks ...

Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life threatening ...

Glaucoma is a devastating eye disease that currently affects more than 3 million Americans. By the year 2050, data shows the number of cases is projected to surge to more than 6 million cases. This is ...